Erdal Sarac is a Nephrology physician affiliated with St. Elizabeth Youngstown Hospital. OpenAlex indexes 49 publications with 201 citations (h-index 8); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
807 Southwestern Run
Poland, OH 445143688
Telephone
330-729-0059Registry record last updated 6 Jan 2016.
Clinical trials
- Safety and Efficacy of Acthar Gel in an Outpatient Dialysis Population
Sponsor: Youngstown State University
Overall officialPhase 1TerminatedNCT02486744
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
34 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Amgen Inc.Program year20249 payments
- CALLIDITAS THERAPEUTICS US INC.Program year20248 payments
- AstraZeneca Pharmaceuticals LPProgram year20246 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
58.2%Calcium channel blocker14.4%Amlodipine Besylate88%Nifedipine Er12%Part D<11 patientsLoop diuretic9%Torsemide52%Bumetanide39%Furosemide9%Part D<11 patients+ 12 more classes in this area
Metabolism & gastrointestinal
26%Vitamin D3 Analog9.9%Calcitriol93%Rayaldee7%Part D<11 patientsSGLT2 inhibitor6.1%Farxiga80%Jardiance20%Part D<11 patients+ 8 more classes in this area
Other
4.8%Phosphate Binder3.2%Sevelamer Carbonate100%Part D≥22 patientsDrugs for treatment of hyperkalemia and hyperphosphatemia1.6%Lokelma100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- An Unusual Presentation of Barakat Syndrome: Gene Deletion at Chromosome 10p15
Case Reports in Nephrology
2025 - The Progressive Decline of Kidney Function: Can We Have an Answer?
Journal of the American Society of Nephrology
2023 - Impact of Development and Severity of AKI on In-Hospital Outcomes Among Patients With COVID-19
Journal of the American Society of Nephrology
2022 - Crescents: An Eclipsed Presentation of Multiple Myeloma
Journal of the American Society of Nephrology
2022
Similar KOLs
Other experts from the same institution or the same specialty.
Andrea Shaer, MD
St. Elizabeth Youngstown Hospital
Hilmer Negrete, MD
St. Elizabeth Youngstown Hospital
Chander Kohli, MD
St. Elizabeth Youngstown Hospital
Timothy Barreiro, DO
St. Elizabeth Youngstown Hospital
Andrew Levey, MD
Tufts Medical Center
Bertram Kasiske, MD
Hennepin Healthcare
Garabed Eknoyan, MD
Baylor College of Medicine
Lawrence Hunsicker, MD
University of Iowa
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”